nephrotic and nephritic syndrome (glomerulonephritis) Flashcards
nephrotic syndrome
proteinuria >3.5 g/day/1.73 m2 hypoalbuminemia <3.5 g/dL edema hyperlipidemia lipiduria
causes of primary idiopathic NS
minimal change disease, membranous nephropathy, focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis (overlap)
causes of secondary NS
minimal change disease, membranous nephropathy, focal segmental glomerulosclerosis, membranoproliferative GN, diabetic nephropathy, amyloid, light change deposition disease
minimal change disease
most cases primary/idiopathic. secondary causes: NSAIDS, malignancies (hematologic)
focal segmental GN
secondary causes: healing of previous glomerular injury, massive obesity, OSA, sickle cell anemia, HIV, pamidronate, heroin abuse
membranous nephropathy
secondary causes: malignancy, primarily solid tumors, class V lupus nephritis, rheumatoid arthritis, hepatitis B and C, drugs, syphilis
definition of GN
intraglomerular inflammation, cellular proliferation, hematuria, excludes nonproliferative disorders
presentation of GN
varies from microscopic asymptomatic hematuria or proetinuria to acute nephritis, to rapidly progressive nephritis.
nephritic syndrome
hematuria-dysmorphic red blood cells, RBC casts azotemia oliguria hypertension variable proteinuria
focal proliferative GN
IGA nephropathy
henoch-schonlein purpura
lupus nephritis (class 1 and 2)
heriditary nephritis (alport’s)
diffuse proliferative GN
poststrep GN bacterial endocarditis lupus nephritis (class IV) membranoproliferative gn crescentic gn vasculitis
IGA nephropathy
common cause of GN mesangioproliferative GN asians and caucasians rare in african americans age 20-30 males>females pathogenesis-altered regulation of IGA
clinical presentation of IGA nephropathy
episodic gross hematuria
persistent microscopic hematuria
acute GN
ESRD
treatment
no cure
N-3 fatty acids (fish oil)
corticosteroids
ace/arbs
henoch-schonlein purpura
systemic IgA nephropathy
- arthralgias
- purpura
- ab pain
- GI bleeding
- hematuria
clinical presentation of poststrep GN
children 2-10 years uncommon over age 40 symptoms develop 7 days to 12 weeks after the infection low complement levels spontaneous recovery is the rule hematuria can persist 6 months proteinuria, mild can persist years
pathogenesis
nephritogenic strains of streptococci
planted antigen
-nephritis associated plasmin receptor GAPDH
-zymogen
host immune response
alternative pathway of complement activation
IgG and C3 found in glomeruli
rapidly progressive GN
GN (nephritic syndrome) rapid decline in renal funcion rare-2-4% of all GN pathologic hallmark crescents calssified based on presence or absence of immune complexes
anti GBM disease presentation
bimodal age distribution (3rd and 6th decades)
pulmonary hemorrhage
malaise, fatigue, anorexia, weight loss, arthralgias, myalgias
caucasians
rare in african americans
pathogenesis of anti GBM disease
antibodies develop against alpha 3 chain type IV collagen in GBM. linear deposition of IgG along GBM. antibodies detected by ELISA. ANCA found in about 30% pts
treatment of anti GBM disease
outcome poor without therapy. corticosteroids alone insufficient. cyclophosphamide, plasma exchange with albumin 14 days. renal recovery rare if pts present needing dialysis